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Abstract
Background The open abdomen has become a common
procedure in the management of complex abdominal
problems and has improved patient survival. The method of
temporary abdominal closure (TAC) may play a role in
patient outcome.
Methods A prospective, observational, open-label study
was performed to evaluate two TAC techniques in surgical
and trauma patients requiring open abdomen management:
Barker’s vacuum-packing technique (BVPT) and the
ABTheraTM open abdomen negative pressure therapy
system (NPWT). Study endpoints were days to and rate of
30-day primary fascial closure (PFC) and 30-day all-cause
mortality.
Results Altogether, 280 patients were enrolled from 20
study sites. Among them, 168 patients underwent at least
48 hours of consistent TAC therapy (111 NPWT, 57
BVPT). The two study groups were well matched demo-
graphically. Median days to PFC were 9 days for NPWT
versus 12 days for BVPT (p = 0.12). The 30-day PFC rate
was 69 % for NPWT and 51 % for BVPT (p = 0.03). The
30-day all-cause mortality was 14 % for NPWT and 30 %
for BVPT (p = 0.01). Multivariate logistic regression
analysis identified that patients treated with NPWT were
significantly more likely to survive than the BVPT patients
[odds ratio 3.17 (95 % confidence interval 1.22–8.26);
p = 0.02] after controlling for age, severity of illness, and
cumulative fluid administration.
Conclusions Active NPWT is associated with signifi-
cantly higher 30-day PFC rates and lower 30-day all-cause
mortality among patients who require an open abdomen for
at least 48 h during treatment for critical illness.
This work was presented as an abstract at the Fifth World Congress
on the Abdominal Compartment Syndrome, Lake Buena Vista,
Florida, August 10–13, 2011.
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Introduction
The ‘‘open abdomen’’ (OA) and temporary abdominal
closure (TAC) techniques have become valuable tools in
the surgeon’s armamentarium. They are part of damage
control strategies and are used in the treatment of abdom-
inal sepsis and intraabdominal hypertension (IAH)/
abdominal compartment syndrome (ACS). The carefully
considered decision to abbreviate a patient’s laparotomy,
leave the abdomen open, and apply a TAC in the presence
of critical illness or intraabdominal catastrophe has been
associated with improved patient survival [1–5]. Manage-
ment of the OA in a patient with concomitant critical ill-
ness is challenging. It is associated with the potential for
marked fluid loss, infection, visceral perforation, organ
dysfunction, and death [6–13]. Prolonged abdominal
decompression can result in intestinal adhesions, fascial
retraction, loss of abdominal domain, formation of enteric
fistulas, and development of massive incisional hernias
requiring subsequent complex abdominal wall reconstruc-
tion [2, 7, 9, 12, 14–18]. Growing clinical experience has
demonstrated that initial management defines the sub-
sequent duration and complexity of the OA [2, 5, 19, 20].
The concept of TAC has steadily evolved over the past
two decades, with a variety of techniques described.
Modern TAC dressings may be classified into two broad
classes based on their function: (1) passive visceral cov-
erage (plastic silos and prosthetic meshes) and (2) negative
pressure techniques that maintain abdominal wall integrity,
preserve abdominal domain, and remove intraperitoneal
fluid [16–18]. Mechanical abdominal wall retraction devi-
ces are increasingly being used in conjunction with TAC
dressings to achieve the desired endpoint of primary fascial
closure (PFC).
Clinical experience demonstrates that simple coverage
of exposed viscera is no longer sufficient. Recent evidence
suggests that the TAC technique chosen may moderate
organ dysfunction and play a role in patient outcome [20,
21]. Animal studies suggest that active removal of cyto-
kine-rich proinflammatory peritoneal fluid from the OA
improves both pulmonary and renal function [21]. Human
clinical trials have demonstrated that negative pressure
wound therapy (NPWT) facilitates same-admission PFC
[5, 22]. Improved resuscitation and earlier closure of the
OA have been correlated with improved patient survival
[2]. Active removal of cytokine-rich proinflammatory
peritoneal fluid and early fascial closure should therefore
be the goals of TAC therapy.
Of the various TAC methods, Barker’s vacuum-packing
technique (BVPT) is the most commonly utilized due to its
simplicity, cost, and availability of necessary materials in
any operating room [16, 23]. The BVPT TAC typically
consists of a fenestrated, nonadherent polyethylene sheet
placed over the viscera and covered with either moist
surgical towels or gauze. Two surgical drains are placed
over the towels or gauze, the abdomen is sealed with a
large adhesive dressing, and the drains are connected to
variable levels of wall suction (Fig. 1). Local variations of
this technique are common.
NPWT techniques utilizing polyurethane foam and
continuous suction are also widely employed to manage the
OA. The ABTheraTM OA Negative Pressure Therapy
System (KCI USA, San Antonio, TX, USA) utilizes a
calibrated negative pressure source, a large visceral pro-
tective layer consisting of a polyurethane film-covered
central foam structure with six arms of polyurethane foam
extending from the center, two pieces of perforated poly-
urethane foam, and adhesive drapes (Fig. 2). The visceral
protective layer is designed to separate the viscera from the
abdominal wall (decreasing visceral adherence that may
prevent subsequent abdominal closure) and remove peri-
toneal fluid from dependent areas of the abdomen such as
the pelvis and paracolic gutters.
No clinical study has demonstrated superiority of one
TAC technique over another. In an effort to evaluate
clinical outcomes of two commonly used techniques, a
prospective, multicenter, open-label, postmarketing evalu-
ation comparing BVPT versus NPWT was performed.
Methods
This was a prospective, multicenter, observational study
with 20 participating trauma centers from across the United
States. This study was registered with ClinicalTrials.gov
(NCT01016353). The institutional review board (IRB) at
each study site approved the study protocol with a waiver
of informed consent given the emergent nature of abdom-
inal decompression. Some study sites were required by
their respective IRB to obtain subsequent informed consent
to collect patient information. Recognizing that one TAC
method or the other was considered ‘‘standard of care’’ at
some centers and a prospective, randomized study design
would not be approved by the IRB at other centers, the
study sites were chosen with the intent that one-fourth of
them would contribute BVPT patients only, one-fourth
would contribute NPWT patients only, and one half would
contribute patients receiving both treatments resulting in
equal enrollment in each study arm.
An open-label, observational study design was chosen
that allowed the surgeons at each study site to utilize the
two TAC techniques and resuscitate patients as they
deemed clinically appropriate. Although the intent of the
study protocol was consistent use of one TAC method or
the other, investigators were allowed to cross patients over
to the other TAC technique at their discretion. Included in
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the study were surgical or trauma patients between 18 and
75 years of age who required either a BVPT or NPWT
TAC following damage control laparotomy or treatment of
either severe sepsis or IAH/ACS.
Patients were excluded if any of the following criteria
were known to be present: pregnancy; active uncontrolled
hemorrhage at the time of initial TAC placement; preex-
isting bleeding disorder; known allergy or hypersensitivity
to polyvinyl, polyurethane, acrylic, or acrylic adhesive;
preexisting abdominal fistulas; Child-Pugh liver dysfunc-
tion class C; body mass index [ 40 kg/m2; New York
Heart Association classification IV; chronic renal failure
requiring dialysis; peritoneal dialysis/lavage; preexisting
terminal illness; or significant abdominal wall defect as
determined by the surgeon at the time of initial TAC
placement.
Patients whose abdominal fascia and skin were not
closed following laparotomy were defined as having an
OA. ‘‘Surgical’’ patients underwent emergent, nontrauma
procedures. ‘‘Trauma’’ patients were classified into ‘‘blunt’’
or ‘‘penetrating’’ categories based on the mechanism of the
injury.
The primary outcome measure was time to, and the rate
of, PFC at 30 days (defined as the act of closing the
Fig. 1 Barker’s vacuum-
packing technique consists of a
fenestrated, nonadherent
polyethylene sheet placed over
the viscera and covered with
moist surgical towels or gauze.
Two drains are placed over the
towels/gauze. The wound is
then sealed with an occlusive
dressing and connected to wall
suction (with permission from
KCI Licensing, Inc.)
Fig. 2 ABTheraTM open-
abdomen negative-pressure
therapy system, commercially
available, is composed of a
reusable negative pressure
source (ABTheraTM pump), a
visceral protective layer
dressing composed of a
nonadherent sheet with
encapsulated foam struts, a
sheet of polyurethane foam, an
adherent elastic barrier layer,
and a tubing set to connect the
negative-pressure source to the
dressing (with permission from
KCI Licensing, Inc.)
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patient’s abdominal fascial defect by direct approximation
of 100 % of its edges). The secondary outcome measure
was 30-day all-cause mortality. Both the primary and
secondary outcome measures were further analyzed
according to the etiology of the patient’s OA (surgical vs.
trauma). Other outcome measures evaluated included hours
of mechanical ventilation, intensive care unit and hospital
length of stay (LOS) and any TAC-related complications
that occurred during the patient’s hospitalization.
Intraabdominal pressure (IAP) measurements were per-
formed at the discretion of the treating physician(s). IAH
was defined as sustained or repeated pathologic elevation
in IAP C12 mmHg [14, 15]. ACS was defined as sustained
IAP [20 mmHg (with or without an abdominal perfusion
pressure \60 mmHg) associated with new organ dysfunc-
tion or failure [14, 15]. The severity of IAH was based on
the highest IAP measured during the study period. Multiple
organ dysfunction syndrome (MODS) was defined as the
development of dysfunction within two or more of the
following organ systems: pulmonary, renal, hepatic,
cardiovascular.
Patient fluid resuscitation volumes were collected over
the first 7 days of TAC therapy and stratified by type:
crystalloid, packed red blood cells (pRBC), fresh frozen
plasma (FFP). Peritoneal fluid drainage from the TAC
dressings was similarly measured. Cumulative fluid bal-
ance over the first 7 days of TAC therapy was analyzed.
Standard demographic data were collected. Severity of
illness was assessed using the Acute Physiology and
Chronic Health Evaluation score (APACHE version III),
the Sequential Organ Failure Assessment (SOFA) score,
and the Injury Severity Score (ISS) (for trauma patients).
As the majority of patients underwent laparotomy on the
day of hospital admission, severity of illness scores were
calculated using the first 24 h of clinical data following
initial TAC placement. Patients were followed for 30 days
from study enrollment and included patient outcome at
hospital discharge (the ‘‘study period’’).
The decision to perform damage control laparotomy,
leave a patient’s abdomen open, and apply a TAC dressing
at the time of initial laparotomy depends on many factors
and varies from surgeon to surgeon. This variability results
in two populations of patients: (1) those whose critical
illness requires ongoing use of an OA with multiple TAC
dressing changes and (2) those whose abdomen can be
successfully closed at the time of the first TAC dressing
change after damage control resuscitation has been
achieved (typically 48 h after initial laparotomy). Patients
with ‘‘early closures’’ have been demonstrated in previous
studies to have a less severe illness, lower complication
rate, and lower mortality than patients who require TAC
therapy for [48 h [24–26]. The ‘‘all patients’’ population
was defined as any patient who underwent either BVPT or
NPWT as their initial TAC method. The ‘‘TAC C 48 h’’
subpopulation was defined a priori as any patient who
underwent either BVPT or NPWT as their initial TAC and
received at least 48 h of consistent therapy. These patients
were believed to represent the patient population of
greatest clinical interest because of their increased com-
plexity and illness severity. The ‘‘TAC \ 48 h’’ subpopu-
lation was defined as all patients who succumbed to their
critical illness, achieved PFC, or received both TAC ther-
apies within 48 h of the initial laparotomy.
The target sample size for this study was based on a
parallel design and determined by an independent Data
Monitoring Committee (DMC) after a planned interim
assessment of the primary and secondary endpoints among
the first 70 patients enrolled. At that time, the 30-day PFC
rate was 65 % for BVPT and 81 % for NPWT. The DMC
recommended that at least 271 evaluable patients would be
required to confirm the 16 % difference in PFC rate
between BVPT and NPWT with a power of 80 % and type
I error rate of 5 %. The final maximum sample size was
increased to 300 patients to allow for patient consent
refusals, major protocol violations, and screening failures.
Patient data were entered into a central web-based elec-
tronic database. Data queries requiring clarification were
documented and returned to the study site for resolution.
Data were analyzed using Statistical Analysis System
(SAS) software (version 9.1.3; SAS Institute, Cary, NC,
USA) and are reported as the mean ± SD, median (inter-
quartile range, or IQR), or percentage. Categoric data were
analyzed using Fisher’s exact test. Continuous data were
analyzed using analysis of variance or Wilcoxon’s rank-
sum test, as appropriate. Median days to PFC, reported for
all patients with failures censored at 30 days, was esti-
mated using Kaplan–Meier curves, which were compared
using the log-rank test. Multivariate logistic regression
analyses were performed to determine which TAC tech-
nique was associated with 30-day PFC and survival uti-
lizing the APACHE III score for severity of illness
adjustment and incorporating all resuscitation variables
determined to be significant by univariate analysis. Kap-
lan–Meier survival curve analysis and the log-rank test
were utilized to compare each TAC technique with regard
to survival over time. Statistical significance was defined as
p \ 0.05.
Results
Between November 2009 and January 2011, 20 study sites
enrolled 283 patients who met the study inclusion and
exclusion criteria (198 trauma, 85 emergency nontrauma)
(Fig. 3). Three patients (2 NPWT, 1 BVPT) were subse-
quently excluded because of protocol violations. A larger
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proportion of NPWT TAC dressings were utilized than
BVPT dressings (178 NPWT, 102 BVPT). Table 1 depicts
the enrollment by study site for the 280 subjects. The
demographics and severity of illness of the all patients
population and the TAC \ 48 h and TAC C 48 h sub-
populations are depicted in Table 2. Overall, surgical
patients were older (51 ± 16 vs. 36 ± 14 years; p \ 0.01),
more likely to be female (42 vs. 15 %; p \ 0.01), and had
higher APACHE III scores (66 ± 23 vs. 54 ± 22;
p \ 0.01) than their trauma counterparts. There were no
significant demographic differences between the all
patients population and the TAC C 48 h subpopulation.
Patients in the TAC \ 48 h subpopulation were less
severely injured than those requiring TAC C 48 h, as
evidenced by lower APACHE III (p \ 0.01) and SOFA
(p \ 0.01) scores. They were also more likely to have
sustained penetrating trauma (p = 0.02). The number of
TAC dressing changes in the all patients population and the
TAC C 48 h subpopulation were similar. The low number
of patients with TAC dressing changes (9 NPWT, 4 BVPT)
in the TAC \ 48 h subpopulation reflects the high per-
centage of patients in this subpopulation (91 %) who
achieved PFC within 48 h of initial laparotomy and did not
require a TAC dressing change.
The demographics of the three populations, stratified by
TAC method, are listed in Table 3. In all three populations,
the NPWT and BVPT groups were well matched. The
indications for TAC were similar between the NPWT and
BVPT groups. The NPWT and BVPT groups underwent a
similar number of TAC dressing changes within all three
populations.
The IAP was measured at the discretion of the patient’s
surgeon, with 14 of 20 enrolling centers measuring IAP. In
all, 97 of the 280 patients (67 NPWT, 30 BVPT) had their
IAP measured at some point during the study, but incon-
sistent measurement (range 1–89 IAP measurements per
patient) prevented meaningful assessment of predecom-
pression or postdecompression values. The mean highest
Fig. 3 Consolidated Standards of Reporting Trials (CONSORT) statement. BVPT Barker’s vacuum packing technique, NPWT negative-pressure
wound therapy, TAC temporary abdominal closure
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Table 1 Patient enrollment by study center
Center All patients group TAC \ 48 h group TAC C 48 h group
NPWT BVPT NPWT BVPT NPWT BVPT
NPWT only
Carolinas MC 28 3 11 3 17 0
USC/LAC 28 1 8 0 20 1
Albert Einstein MC 12 0 5 0 7 0
University of Oklahoma MC 7 0 3 0 4 0
University of Kentucky MC 5 0 2 0 3 0
BVPT only
University of Pennsylvania MC 1 12 0 9 1 3
UTHC—San Antonio 0 8 0 8 0 8
University of Louisville MC 0 7 0 4 0 3
Ben Taub General Hospital 0 4 0 1 0 3
University of Rochester MC 0 3 0 2 0 1
NPWT and BVPT
Orlando Regional MC 19 13 5 7 14 6
University of Tennessee—Memphis MC 10 17 6 9 4 8
Oregon Health & Science Center 10 16 3 6 7 10
UTHC—Houston 25 0 16 0 9 0
University of Maryland Medical Center 4 10 1 1 3 9
Tulane University MC 14 0 5 0 9 0
Thomas Jefferson University MC 8 0 1 0 7 0
Scott & White MC 4 3 1 1 3 2
Shand’s Hospital/University of Florida 1 4 0 2 1 2
University of South Alabama MC 2 1 0 0 2 1
NPWT negative pressure wound therapy, TAC temporary abdominal closure, BVPT Barker’s vacuum pack therapy, MC Medical Center, UTHC
University of Texas Healthsciences Center, USC/LAC University of Southern California/Los Angeles County
Table 2 Demographics
Parameter All patients group TAC \ 48 h group TAC C 48 h group p*
Patients (no.) 280 112 168
Age (years) 40 ± 16 39 ± 16 41 ± 16 0.30
Sex (% male) 77 79 76 0.47
BMI (kg/m2) 28 ± 5 (280) 28 ± 5 (112) 29 ± 5 (168) 0.19
APACHE III 58 ± 23 (277) 51 ± 21 (109) 62 ± 24 (168) \0.01
SOFA 8 ± 4 (274) 6 ± 3 (109) 8 ± 4 (165) \0.01
ISSa 28 ± 14 (198) 26 ± 12 (88) 29 ± 15 (110) 0.36
TAC dressing changes 2 ± 3 (280) 0 ± 1 (112) 4 ± 3 (168) \0.01
Injury
Surgical 29 % (82) 21 % (24) 35 % (58) 0.02
Trauma
Blunt 33 % (92) 32 % (36) 33 % (56) 0.90
Penetrating 38 % (106) 46 % (52) 32 % (54) 0.02
Numbers in parentheses are the number of patients
BMI body mass index, APACHE III Acute Physiology and Chronic Health Evaluation score, version III, SOFA Sequential Organ Failure
Assessment, ISS Injury Severity Score
* Continuous variables were compared between TAC \ 48 h and TAC C 48 h using Wilcoxon’s rank sum test. Discrete variables were
compared between TAC \ 48 h and TAC C 48 h with Fisher’s exact test
a Trauma patients only
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IAP measured during the study period was 17 ± 6 mmHg
in the NPWT group and 19 ± 7 mmHg in the BVPT group
(p = 0.17). Within the TAC C 48 h subpopulation, the
mean highest IAP was 18 ± 6 mmHg in the NPWT group
(n = 49) and 19 ± 7 mmHg in the BVPT group (n = 17)
(p = 0.41).
Within the TAC C 48 h subpopulation, the study day 7
total fluid balance was significantly lower in the NPWT
group compared to that in the BVPT group (16 ± 15 vs.
27 ± 28 L; p = 0.04), but total peritoneal fluid output did
not differ (8 ± 7 vs. 10 ± 11 L; p = 0.44). pRBC trans-
fusion did not differ between the NPWT and BVPT groups
(4 ± 6 vs. 10 ± 11 L; p = 0.29). In contrast, FFP trans-
fusion was significantly less in the NPWT group (3 ± 4 vs.
5 ± 6 L; p = 0.03). Perioperative blood product adminis-
tration among NPWT versus BVPT patients achieved
similar pRBC/FFP/PLT ratios: 1.0:1.2:0.2 versus
1.0:1.0:0.2.
Within the TAC C 48 h surgical subpopulation, the
hours of mechanical ventilation (196 ± 197 vs. 277 ±
189 h; p = 0.05), intensive care unit LOS (16 ± 13 vs.
21 ± 19 days; p = 0.16), and hospital LOS (27 ± 17 vs.
33 ± 23 days; p = 0.27) were shorter in NPWT patients,
but the differences did not achieve statistical significance.
Among trauma patients, there were no significant differ-
ences in hours of mechanical ventilation (350 ± 384 vs.
260 ± 190 h; p = 0.49) and intensive care unit LOS
(22 ± 18 vs. 19 ± 17 days; p = 0.16). Hospital LOS did
differ significantly between NPWT and BVPT trauma
patients (43 ± 36 vs. 28 ± 22 days; p = 0.02). When
stratified by severity of illness using APACHE III quartiles,
there were no significant differences in hospital LOS
between the NPWT and BVPT treatment groups. There
were also no significant differences in complication rates
between the NPWT and BVPT groups in either the all
patients or TAC C 48 h populations, although there was a
trend toward less MODS in the NPWT group (Table 4).
The primary and secondary outcome measures for all
three study populations are shown in Table 5. The 30-day
PFC rate was significantly higher for days to PFC and
30-day all-cause mortality significantly lower in the
TAC \ 48 h subpopulation than in the TAC C 48 h
Table 3 Demographics by the TAC method
Parameter All patients group TAC \ 48 h group TAC C 48 h group
NPWT BVPT p NPWT BVPT p NPWT BVPT p
Patients (no.) 178 102 67 45 111 57
Age (years) 40 ± 17 39 ± 16 0.87 38 ± 17 40 ± 15 0.43 42 ± 16 39 ± 16 0.47
Sex (% male) 80 % (142) 73 % (74) 0.18 81 % (54) 78 % (35) 0.81 79 % (88) 68 % (39) 0.13
Injury
Surgical 29 % (52) 29 % (30) 1.00 21 % (14) 22 % (10) 1.00 34 % (38) 35 % (20) 1.00
Trauma
Blunt 34 % (60) 31 % (32) 0.79 31 % (21) 33 % (15) 0.84 35 % (39) 30 % (17) 0.60
Penetrating 37 % (66) 39 % (40) 0.80 48 % (32) 44 % (20) 0.85 31 % (34) 35 % (20) 0.60
BMI (kg/m2) 28 ± 5 (178) 28 ± 5 (102) 0.89 28 ± 5 (67) 28 ± 6 (45) 0.63 29 ± 5 (111) 29 ± 5 (57) 0.69
APACHE III 57 ± 24
(176)
58 ± 23
(101)
0.61 50 ± 22
(65)
53 ± 21
(44)
0.32 61 ± 24
(111)
62 ± 24
(57)
0.76
SOFA 8 ± 4 (172) 7 ± 4 (102) 0.58 6 ± 3 (64) 6 ± 3 (45) 0.74 8 ± 4 (108) 8 ± 4 (57) 0.91
ISSa 28 ± 15
(126)
29 ± 12 (72) 0.26 26 ± 14
(53)
27 ± 11
(35)
0.37 29 ± 16 (73) 30 ± 14
(37)
0.42
Indications for TAC 0.28 0.05 0.73
ACS 8 % (14) 9 % (9) 2 % (1) 4 % (2) 12 % (13) 12 % (7)
Damage control
laparotomy
56 % (100) 63 % (64) 60 % (40) 62 % (28) 51 % (56) 57 % (34)
Abdominal sepsis 22 % (39) 13 % (13) 21 % (14) 4 % (2) 23 % (25) 19 % (11)
Surgeon suspected IAH 11 % (20) 15 % (15) 10 % (7) 24 % (11) 12 % (13) 7 % (4)
Otherb 3 % (5) 1 % (1) 8 % (5) 4 % (2) 4 % (4) 2 % (1)
No. of dressing changes 3 ± 3 (178) 2 ± 3 (102) 0.34 0 % (67) 0 ± 1 (45) 0.5 4 ± 3 (111) 4 ± 3 (57) 0.83
Numbers in parentheses are the numbers of patients
ACS abdominal compartment syndrome, IAH intraabdominal hypertension
a Trauma patients only
b Dehiscence, fluid overload, retroperitoneal edema
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subpopulation. Among patients requiring a TAC for at least
48 h, the 30-day PFC rate was significantly higher in
patients treated with NPWT for all indications except
penetrating trauma (Table 6). Median days to PFC were
lower among NPWT patients than among BVPT patients,
but the difference did not achieve statistical significance.
Patient characteristics significantly associated with suc-
cessful 30-day PFC in a univariate analysis included use of
a NPWT TAC, lower APACHE III score, decreased FFP
requirement, lower peritoneal fluid output, and lower
cumulative fluid balance on study day 7 (Table 7).
The 30-day all-cause mortality was significantly lower
among patients treated for at least 48 h with a NPWT TAC
(Table 8). When stratified by severity of illness, the mor-
tality difference between NPWT and BVPT patients was
most pronounced for patients in the middle two APACHE
III quartiles. Patient characteristics significantly associated
with decreased 30-day mortality in the univariate analysis
included younger age; use of a NPWT TAC; lower
APACHE III, SOFA, and ISS scores; successful 30-day
PFC; decreased FFP requirement; lower peritoneal fluid
output; and a lower cumulative fluid balance on study day 7
(Table 9). Kaplan–Meier survival curve analysis demon-
strated that patients treated consistently for at least 48 h
with NPWT were significantly more likely to survive
30 days than patients treated with BVPT (p = 0.01)
(Fig. 4).
30-day PFC rate varied widely by study site from 0 to
100 % with an overall rate of 74 %. Median days to PFC
also varied widely by study site from 3 to 12 days.
Multivariate logistic regression analysis was performed to
adjust for confounding factors by inclusion of variables
associated with successful 30-day PFC. Although there was
a trend toward an increased likelihood of 30-day PFC
among patients managed with NPWT in the TAC C 48 h
subpopulation [odd’s ratio 2.00 (0.98–4.08); p = 0.06], no
variables in the model achieved significance in this
analysis.
Multivariate logistic regression analysis was performed
to adjust for potential confounding factors independently
associated with 30-day survival including age, APACHE-
III score (to adjust for severity of illness), and cumulative
resuscitation fluids at study day seven. Patients treated with
NPWT for at least 48 h were significantly more likely to
survive compared to BVPT patients [odd’s ratio 3.17
(1.22–8.26); p = 0.02] (Table 10).
Discussion
Widespread use of damage-control principles for life-
threatening abdominal conditions, recognition and treat-
ment of IAH/ACS, and a new understanding of severe
abdominal sepsis have resulted in an increase in the num-
ber of patients treated with an OA. The TAC method uti-
lized for such OAs may play a significant role in patient
outcome. Over the past decade, TAC has evolved from a
simple, passive dressing of necessity to control massively
distended viscera and organs into an active, therapeutic
tool that potentially reduces elevated IAP, protects the
Table 4 Complications
Complication All patients group TAC C 48 h group
NPWT BVPT p NPWT BVPT p
Abdominal abscess/infection 23 % (40) 26 % (26) 0.56 22 % (24) 25 % (14) 0.70
ACS 8 % (14) 8 % (8) 1.00 4 % (4) 2 % (1) 0.66
Abdominal wound dehiscence 2 % (3) 1 % (1) 1.00 2 % (2) 0 % 0.55
Anastomotic leak 4 % (7) 2 % (2) 0.49 5 % (5) 2 % (1) 0.67
Application site erosion 0 % 1 % (1) 0.36 0 % 2 % (1) 0.34
Coagulopathy 5 % (9) 5 % (5) 1.00 1 % (1) 2 % (1) 1.00
DVT 3 % (5) 4 % (4) 0.73 5 % (5) 2 % (1) 0.67
Fascial necrosis 2 % (4) 5 % (5) 0.29 4 % (4) 7 % (4) 0.45
GI ischemia/necrosis 7 % (13) 3 % (3) 0.18 10 % (11) 7 % (4) 0.78
Intestinal fistula 4 % (7) 4 % (4) 1.00 5 % (6) 7 % (4) 0.74
Intestinal obstruction 3 % (5) 0 % 0.16 3 % (3) 0 % 0.55
MODS 8 % (15) 16 % (16) 0.08 10 % (11) 19 % (11) 0.10
PE 1 % (1) 0 % 1.00 1 % (1) 0 % 0.34
Numbers in parentheses are the numbers of patients
ACS abdominal compartment syndrome, DVT deep vein thrombosis, GI gastrointestinal, MODS multiple organ dysfunction syndrome, PE
pulmonary embolism
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abdomen from heat and fluid loss, removes proinflamma-
tory cytokine-rich peritoneal fluid, and facilitates early
PFC.
The success of OA management in many centers has
been due, at least in part, to use of the ‘‘vacuum packing’’
technique described by Barker et al. [16]. This simple TAC
method utilizes dressing supplies that are readily available
in any operating room. Widely performed with numerous
modifications, BVPT reduces elevated IAP by increasing
the abdominal cavity volume, decreasing heat and fluid
losses from exposed viscera, and controlling and quanti-
fying fluid drainage from the OA.
The ABTheraTM system represents an advance in TAC
therapy, performing the usual goals of expanding the
abdominal cavity, protecting the viscera from heat and
evaporative losses, and controlling and quantifying
abdominal fluid. In addition, the large visceral protective
layer can be positioned such that it actively removes
potentially detrimental peritoneal fluid from deep within
the abdomen while simultaneously decreasing visceral
adherence to the abdominal wall. This study identifies that
active NPWT is associated with significantly higher 30-day
PFC rates and lower 30-day all-cause mortality among
patients who require an OA for at least 48 h. Improved
PFC rates have been demonstrated to correlate with sig-
nificant increases in patient survival and decreases in
hospital charges [2, 20]. Same-admission PFC, thereby
avoiding an incisional hernia and the need for subsequent
complex abdominal wall reconstruction, should be the goal
in any patient who requires OA management.
This is the first study to demonstrate a survival advan-
tage associated with a particular TAC technique. Although
demographics, severity of illness, and indications for TAC
were similar in the two treatment groups, the cumulative
resuscitation requirement was significantly higher and
more variable in the BVPT group. This difference may
initially suggest a difference in fluid resuscitation strategy,
but the increased fluid requirement may also be indicative
of ongoing sepsis and inflammation in patients treated with
a BVPT TAC, as suggested by the almost twofold higher
rate of MODS among BVPT patients despite similar initial
severity of illness. The difference in mortality rate between
the NPWT and BVPT groups progressively widened over
the first 30 days, consistent with late deaths due to MODS
among the BVPT patients (Fig. 4). This raises the question
of whether active NPWT more effectively removes detri-
mental cytokine-rich peritoneal fluid from the OA, reduc-
ing organ dysfunction and alleviating critical illness as
Table 5 Patient outcome by study group
Outcome indicators All patients group TAC \ 48 h group TAC C 48 h group p
Patients (no.) 280 112 168
30-Day PFC rate 74 % (208) 91 % (102) 63 % (106) \0.01*
Interval to PFC (days)a 5 [3–12] 3 [2–3] 9 [5–15] \0.01
30-Day all-cause mortality rate 15 % (41) 8 % (9) 19 % (32) 0.01*
Numbers in parentheses are the numbers of patients
PFC primary fascial closure, IQR interquartile range
*Fisher’s exact test
a Median [IQR]. The median days were estimated using Kaplan–Meier curves and were compared using the log-rank test
Table 6 30-Day primary fascial closure
Parameter All patients group TAC \ 48 h group TAC C 48 h group
NPWT BVPT p NPWT BVPT p NPWT BVPT p
Patients (no.) 178 102 67 45 111 57
All patients 78 % (139) 68 % (69) 0.06 93 % (62) 89 % (40) 0.74 69 % (77) 51 % (29) 0.03
Injury
Surgical 75 % (39) 53 % (16) 0.05 79 % (11) 80 % (8) 1.00 74 % (28) 40 % (8) 0.02
Trauma
Blunt 75 % (45) 56 % (18) 0.10 91 % (19) 87 % (13) 1.00 67 % (26) 29 % (5) 0.02
Penetrating 83 % (55) 88 % (35) 0.59 100 % (32) 95 % (19) 0.38 68 % (23) 80 % (16) 0.37
Interval to PFC (days)a 4 (3–11) 5 (3–17) 0.29 3 (2–3) 3 (2–4) 0.19 9 (4–18) 12 (5–NC) 0.12
Numbers in parentheses are the numbers of patients
NC not calculable
Median [IQR]. The median days were estimated using Kaplan–Meier curves and were compared using the log-rank test
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suggested in previous animal studies. Clinical studies are
currently underway to determine the efficacy of peritoneal
cytokine removal by these two TAC techniques to further
clarify this important question.
If improved peritoneal cytokine removal is the mecha-
nism for the higher PFC and lower mortality rates wit-
nessed in the NPWT treatment group, one might anticipate
higher peritoneal fluid output in such patients. This study
identified a nonsignificant trend toward higher peritoneal
fluid output in the BVPT group. As total fluid intake is
clinically correlated with peritoneal fluid output, we
believe that the increased fluid requirement of the BVPT
group may have driven the higher peritoneal fluid volumes
seen and explain the lack of difference in peritoneal fluid
removal between NPWT and BVPT patients. The clinical
trials currently being performed should answer this
question.
The safety of NPWT remains a concern for some sur-
geons. The incidence of critical complications such as
development of ACS or an intestinal fistula during TAC
therapy did not differ between the two study groups. The
importance of serial IAP monitoring to diagnose recurrent
ACS in patients with an OA and TAC cannot be overem-
phasized [27]. Recurrent ACS may occur with any TAC
technique, especially in cases with active bleeding and
clotted hemoperitoneum, which prevents effective removal
of any intraperitoneal fluid. ACS, which may be related to
worsening of the patient’s critical illness, is frequently
attributed to an inadequate laparotomy incision or pre-
mature tightening of the TAC closure.
This observational study has several limitations. First,
although the preferred methodology for an evaluation of
these two TAC methods would be a randomized controlled
trial, the IRB requirement to obtain informed consent prior
to randomization of patients to either TAC technique dur-
ing the initial application would have prevented study
completion due to the lack of patient acuity and the fre-
quent unavailability of family members to give consent.
Table 7 30-Day patient characteristics at study day 7 in the
TAC C 48 h subpopulation, by the PFC result
Characteristic Successful
PFC
Unsuccessful
PFC
p
Patients (no.) 106 62
Age (years) 40 ± 17 43 ± 16 0.20
APACHE III score 58 ± 23 68 ± 24 \0.01
SOFA score 8 ± 3 9 ± 4 0.11
ISS scorea 28 ± 14 32 ± 16 0.29
Indications for TAC 0.40
ACS 9 % (9) 18 % (11)
Damage control
laparotomy
57 % (60) 48 % (30)
Abdominal sepsis 22 % (23) 21 % (13)
Surgeon suspected IAH 9 % (10) 11 % (7)
Otherb 4 % (4) 2 % (1)
TAC method 0.02
NPWT 73 % (77) 55 % (34)
BVPT 27 % (29) 45 % (28)
Crystalloid (L) 21.8 ± 15.4 24.7 ± 18.9 0.71
pRBC (L) 4.7 ± 7.8 5.4 ± 8.2 0.86
FFP (L) 2.8 ± 4.3 4.6 ± 5.5 0.01
Peritoneal fluid output (L) 6.7 ± 6.9 11.7 ± 10.6 \0.01
Fluid balance (L) 15.6 ± 17.5 26.4 ± 24.6 \0.01
Numbers in parentheses are the numbers of patients
pRBC packed red blood cells, FFP fresh frozen plasma
a Trauma patients only
b Dehiscence, fluid overload, retroperitoneal edema
Table 8 30-Day all-cause patient mortality rates
Parameter All patients TAC \ 48 h TAC C 48 h
NPWT BVPT p NPWT BVPT p NPWT BVPT p
Patients (no.) 178 102 67 45 111 57
All patients 12 % (21) 20 % (20) 0.08 9 % (6) 7 % (3) 0.74 14 % (15) 30 % (17) 0.01
Reason for laparotomy
Surgical 17 % (9) 30 % (9) 0.27 21 % (3) 20 % (2) 1.00 16 % (6) 35 % (7) 0.11
Trauma
Blunt 15 % (9) 25 % (8) 0.27 10 % (2) 0 % (0) 0.50 18 % (7) 47 % (8) 0.05
Penetrating 5% (3) 8 % (3) 0.67 3 % (1) 5 % (1) 1.00 6 % (2) 10 % (2) 0.62
APACHE III
B40 5 % (2) 4 % (1) 1.0 0 % (0) 0 % (0) 1.00 11 % (2) 8 % (1) 1.00
41–53 0 % 5 % (1) 0.31 0 % (0) 0 % (0) 1.00 0 % (0) 11 % (1) 0.23
54–72 14 % (6) 25 % (7) 0.35 25 % (3) 0 % (0) 0.22 10 % (3) 41 % (7) 0.02
C73 30 % (13) 42 % (11) 0.43 30 % (3) 43 % (3) 0.64 30 % (10) 42 % (8) 0.55
Numbers in parentheses are the numbers of patients
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An open-label, observational study design with a waiver of
informed consent was therefore chosen affording a ‘‘real-
world’’ comparative effectiveness analysis of these two TAC
techniques. This allowed surgeons to choose the TAC
dressing that they believed was clinically indicated. Overall,
surgeons elected to employ NPWT to a greater extent than
BVPT, resulting in an uneven enrollment of subjects,
although similar demographics and severity of illness, in
each study arm. In this analysis, NPWT was independently
associated with significantly better 30-day survival in
patients who received at least 48 h of consistent TAC ther-
apy. Sensitivity analyses of the study data stratified by high-
enrolling centers and those that enrolled both NPWT and
BVPT patients showed similar results regarding the survival
benefit of NPWT. Second, we did not query the surgeons at
the time of initial TAC placement as to the rationale behind
their choice of TAC dressing. At many centers, this infor-
mation would have been irrelevant as the standard of care
was to use one TAC technique or the other. We cannot
therefore determine whether patient-specific factors led to
the surgeon’s choice of TAC method and the improved
survival and PFC rate in the NPWT group. Third, it is diffi-
cult to evaluate the impact of NPWT on IAP in this patient
population as IAP measurements were performed in only
35 % of the study patients. Goal-directed resuscitation using
IAP measurements has been associated with improved
patient survival [2]. Fourth, the source of the significant
survival benefit of NPWT remains unclear. Patients who
received TAC therapy for\48 h clearly differ in severity of
illness and subsequent survival from those who received
consistent TAC therapy for C48 h. We believe that at least
some of these ‘‘early closure’’ patients may not have required
an OA, and their inclusion in the study analyses would serve
only to obscure the potential treatment benefits of the two
Table 9 Survivor characteristics at study day 7 in the TAC C 48 h
subpopulation
Characteristic Survivors Nonsurvivors p
Patients (no.) 136 32
Age (years) 39 ± 16 50 ± 14 \0.01
APACHE III score 58 ± 23 76 ± 22 \0.01
SOFA score 8 ± 4 10 ± 3 \0.01
ISS scorea 27 ± 14 40 ± 16 \0.01
Indications for TAC 0.44
ACS 10 % (13) 22 % (7)
Damage control laparotomy 55 % (75) 47 % (15)
Abdominal sepsis 22 % (30) 19 % (6)
Surgeon suspected IAH 10 % (14) 9 % (3)
Otherb 3 % (4) 3 % (1)
TAC method 0.01
NPWT 71 % (96) 47 % (15)
BVPT 29 % (40) 53 % (17)
30-Day PFC 71 % (97) 28 % (9) \0.01
Crystalloid (L) 21.3 ± 14.6 29.5 ± 23.1 0.06
pRBC (L) 4.9 ± 8.1 5.2 ± 7.3 0.68
FFP (L) 3.1 ± 4.5 5.1 ± 5.9 0.01
Peritoneal fluid output (L) 7.5 ± 7.2 12.8 ± 12.7 0.02
Fluid balance (L) 15.9 ± 17.2 35.4 ± 27.5 \0.01
Numbers in parentheses are the numbers of patients
a Trauma patients only
b Dehiscence, fluid overload, retroperitoneal edema
Fig. 4 Kaplan–Meier plot of time to death for the TAC C 48 h
population
Table 10 Multivariate logistic regression analysis of 30-day survival
controlling for age, severity of illness, and cumulative fluids at study
day 7
Factor Odds ratio 95 % CI p
All patients
NPWT 2.05 0.91–4.59 0.08
Age (years) 0.96 0.93–0.99 0.04
APACHE III (per point) 0.97 0.95–0.99 \0.01
Crystalloid (L) 0.96 0.94–0.99 \0.01
pRBCs (L) 1.27 1.07–1.51 \0.01
FFP (L) 0.72 0.59–0.88 \0.01
Peritoneal fluid output (L) 0.98 0.92–1.05 0.59
Total fluid output (L) 1.02 0.98–1.05 0.20
TAC C 48 h
NPWT 3.17 1.22–8.26 0.02
Age (years) 0.95 0.91–0.98 \0.01
APACHE III (per point) 0.99 0.97–1.01 0.23
Crystalloid (L) 0.97 0.94–0.99 0.01
pRBCs (L) 1.27 1.07–1.51 \0.01
FFP(L) 0.72 0.59–0.88 \0.01
Peritoneal fluid output (L) 0.99 0.93–1.07 0.87
Total fluid output (L) 1.01 0.97–1.05 0.54
Numbers in parentheses are the numbers of patients
CI confidence interval
2028 World J Surg (2013) 37:2018–2030
123
TAC methods. The decreased number of patients in the a
priori defined TAC C 48 h subpopulation did result in
reduced statistical power, which may be concealing causa-
tive factors for the treatment benefit identified that would be
apparent in a larger study. Although our findings could be
related to differences in resuscitation technique among study
sites, the analyses performed thus far do not support this idea
and suggest that a true treatment benefit exists. Fifth, marked
variability in patient pathophysiology and differences in
surgical management of the OA may have an impact on the
success of OA closure. The large number of sites and
observational nature of the study limited our ability to ana-
lyze these complex patterns of variability regarding both rate
of, and days to, PFC. This may have obscured identification
of factors independently predictive of successful 30-day PFC
in the multivariate logistic regression analysis.
Conclusions
A negative pressure therapy system was associated with
significantly higher 30-day PFC rates and lower 30-day all-
cause mortality among patients who required an OA for at
least 48 h during treatment of their critical illness. Further
investigation is required to determine the etiologies of
these significant benefits in patient care and outcome.
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